Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02416986 · ClinicalTrials.gov registry record · NA

Effects of Smoking Environment on Craving and Smoking

A NA study of Smoking, sponsored by Duke University.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT02416986: Completed NA study of Smoking, sponsored by Duke University.

NCT02416986 is a NA study of Smoking that has completed, run by Duke University. The registered enrollment target is 41 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02416986, a NA study of Smoking, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate the effects of exposure to standard smoking environments on ability to resist smoking as measured with a Delay to Smoking Task. The results of this study will inform whether the Delay to Smoking Task is a sensitive measure for evaluating environment-provoked craving and smoking behavior.

Conditions Studied

Interventions

  • BEHAVIORAL 6 hour smoking abstinence
  • BEHAVIORAL Delay to Smoking Task (smoking cues)
  • BEHAVIORAL Delay to Smoking Task (nonsmoking cues)

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2014-10
Est. Completion 2015-12
Phase NA
Duke University

1,725 total trials

What the finished NCT02416986 record still lists

NCT02416986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 3 interventions - of which 6 hour smoking abstinence is the first listed.

NCT02416986 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02416986 about?

NCT02416986 is a clinical study titled "Effects of Smoking Environment on Craving and Smoking". The goal of this study is to evaluate the effects of exposure to standard smoking environments on ability to resist smoking as measured with a Delay to Smoking Task. The results of this study will inform whether the Delay to Smoking Task is a sensitive measure for evaluating environment-provoked cra...

What is the current status of trial NCT02416986?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-10. Estimated completion is 2015-12.

What conditions does trial NCT02416986 study?

This clinical trial studies the following conditions: Smoking.

What interventions are being tested in trial NCT02416986?

The interventions under investigation include: 6 hour smoking abstinence (BEHAVIORAL), Delay to Smoking Task (smoking cues) (BEHAVIORAL), Delay to Smoking Task (nonsmoking cues) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02416986?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02416986 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02416986's enrollment target sits among peer trials

41 101st of 123 higher than 23 of 123 other Smoking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02416986, the US trial registry maintained by the National Library of Medicine. NCT02416986 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.